Implementing R and D policies: an analysis of Spain's pharmaceutical research program
Clara Eugenia García,
Praveen Kujal () and
Félix Lobo ()
UC3M Working papers. Economics from Universidad Carlos III de Madrid. Departamento de Economía
Using detailed firm-level data, we analyze Spain's Pharmaceutical Research Program, and find differences between the ex ante announced evaluation criteria and their ex post implementation. By studying the program's implementation, we also uncover that the apparent discrimination against non-European firms is due to the heavy penalty placed on not having local production plants. In this sense the R and D support program works in part as a production support program. Our analysis suggests that the design of public R and D programs cannot be judged exclusively on their results. Analyzing the implementation stage is equally important.
New Economics Papers: this item is included in nep-com, nep-ino and nep-tid
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:cte:werepe:we035923
Access Statistics for this paper
More papers in UC3M Working papers. Economics from Universidad Carlos III de Madrid. Departamento de Economía
Bibliographic data for series maintained by Ana Poveda ().